Christopher Viehbacher

migrate wildebeest safari Africa animals herd crowd stampede

Biotech

Biogen 'could migrate' to immunology, with $10B 'dry powder'

Long known as a neuroscience company, Biogen “could migrate” into immunology, CEO Christopher Viehbacher signaled Tuesday.

Annalee Armstrong Apr 25, 2023 10:47am

business development open door opportunity push

Biogen's brand-new CEO moves immediately for pipeline rebuild

Feb 15, 2023 10:30am

money

Ito out at PureTech, MIT after Epstein scandal

Sep 9, 2019 5:06am